Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial.

Cancer Biomark · 2025 · PMC12288376 · PMID 39058439

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

did not reach statistical significanceP = 0.084so close (0.05 < p ≤ 0.1)

other NSCLC was greater in the LDCT-arm (23/142 = 16.2%) than the CXR-arm (1/32 = 3.1%) but did not reach statistical significance ( P = 0.084).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.